◼ Archived
Business
What to know about GLP-1s and cannabis use
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Zepbound
19 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
GLP-1 injections recalled nationwide. See affected products
19 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
#EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Experimental Lilly combination drug tops Zepbound in weight-loss trial
An experimental combination drug from Eli Lilly outperforms Zepbound in a new weight-loss trial.
◼ Archived
Health
Zepbound Is Known for Weight Loss, but Scientists Just Found Something Unexpected
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
What GLP-1 users should know about the potential risk of a rare type of vision loss
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
Recent studies indicate that popular weight-loss treatments manufactured by Novo Nordisk and Eli Lilly retain efficacy at reduced doses.
◼ Archived
Health
🔮 fades ✓
GLP-1 weight-loss drugs show promise for sleep apnea
New research indicates GLP-1 weight-loss medications like Mounjaro and Zepbound may offer therapeutic benefits for the one billion people with sleep apnea.
◼ Archived
Health
🔮 fades ✗
Wegovy and Zepbound are changing how Americans get health care
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
New Research Shows a Strong Link Between This GLP Medication and Hair Loss. Experts Weigh In.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
GLP-1s Left Their Hair 'Falling Out In Fistfuls'
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Options market braces for $225 billion swing in SpaceX's value as earnings loom
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Should We Be Concerned About Muscle Loss With GLP-1s?
Medical experts and news outlets are raising alarms over potential muscle loss and frailty risks associated with GLP-1 weight loss drugs in older populations.
◼ Archived
Business
🔮 fades ✓
Some people are getting shut out when it comes to GLP-1 drugs. Here’s why.
Patients are facing restricted access to GLP-1 drugs like Ozempic and Wegovy due to high costs and restrictive insurance policies.
◼ Archived
Business
🔮 fades
Medicare is about to cover GLP-1 drugs for weight loss. Here’s what to know.
Medicare initiates a pilot program providing coverage for GLP-1 weight-loss medications beginning July 1, 2026.
◼ Archived
Business
🔮 fades
Seniors in Medicare are about to get landmark obesity drug coverage
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.